Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

Objective: To study the safety and efficacy of a cholinesterase inhibitor, donepezil hydrochloride, for the treatment of dementia in Parkinson's disease (PD). Methods: This was a randomised double blind, placebo controlled, crossover study in 22 subjects with PD and dementia. Participants were...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ravina, B, Putt, M, Siderowf, A, Farrar, J, Gillespie, M, Crawley, A, Fernandez, H, Trieschmann, M, Reichwein, S, Simuni, T
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2005
Aiheet:
Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1739697/
https://ncbi.nlm.nih.gov/pubmed/15965198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2004.050682
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia